Hung David
- SEC CIK
- 0001310880
In the past year, 1 open-market sale filing worth $46.4K and no purchases.
Current role at each company
- NVCR NovoCure LtdDirectoras of Jun 5, 2026
- NUVB Nuvation Bio Inc.PRESIDENT AND CEOas of Mar 3, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $46.4K
- 1 filing
- Net
- −$46.4K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Hung David as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
NVCR NovoCure Ltd
Director2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 3, 2026 (view filing) | Jun 2 | 1 day | Hung DavidDirector | SSale | −2.94K | $15.77 | −$46.4K | −12.6%20.5K after | |
| Jun 4, 2025 (view filing) | Jun 3 | 1 day | Hung DavidDirector | SSale | −999 | $17.30 | −$17.3K | −7.6%12.2K after |
NUVB Nuvation Bio Inc.
PRESIDENT AND CEO2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 18, 2025 (view filing) | Jun 16 | 2 days | Hung DavidPRESIDENT AND CEO | PPurchaseClass A Common Stock | +500.0K | $1.79 | +$895.0K | +0.9%59.3M after | |
| Apr 8, 2025 (view filing) | Apr 4-7 | 4 days | Hung DavidPRESIDENT AND CEO | PPurchaseClass A Common Stock | +500.0K | $1.64 | +$821.0K | +0.9%58.8M after | 2 lots |